Newborn jaundice is one of the most common reasons a healthy-term baby gets a second look before discharge, and the 2022 American Academy of Pediatrics (AAP) guideline revision changed how nurses screen, escalate, and teach families about it. The clinical thresholds shifted, but the bedside priorities stayed familiar: measure every baby, match the number to the right curve, and make sure the family knows exactly what to watch for and when to come back.
What the 2022 update changed for the bedside
The revised guideline covers infants born at 35 or more weeks of gestation and reorganizes management into prevention, assessment, treatment, follow-up, and institutional policy. Two changes matter most at the bedside.
First, the AAP reinforced universal predischarge bilirubin screening. Every newborn should have a total serum bilirubin (TSB) or transcutaneous bilirubin (TcB) measured before discharge, not only the babies who look yellow. Visual estimation alone is unreliable, especially in infants with darker skin tones, so the number drives the decision.
Second, the phototherapy and exchange transfusion thresholds were raised by a narrow margin. Newer evidence indicates bilirubin causes neurotoxicity at higher concentrations than the 2004 guideline assumed. The new nomograms also fold gestational age in along a continuum rather than in broad steps. Practically, this means a TSB that would have triggered phototherapy under the old curves may now warrant close follow-up instead. The judgment is no longer yours to eyeball at the bedside. You plot the hour-of-life value against the correct gestational-age and risk curve in your facility's tool or EHR calculator.
Measure bilirubin on every baby before discharge. The number, plotted against the right curve for that infant's age and risk, is what tells you who needs phototherapy and who needs a return visit.
Risk factors and follow-up timing
The guideline separates two distinct risk pictures, and nurses should keep them straight in handoff and documentation.
Risk factors for developing significant hyperbilirubinemia include lower gestational age, jaundice in the first 24 hours, hemolysis (including ABO or Rh incompatibility and G6PD deficiency), exclusive breastfeeding with suboptimal intake, significant weight loss, and a sibling who needed phototherapy.
Hyperbilirubinemia neurotoxicity risk factors are a separate list that lowers the phototherapy threshold when present: gestational age under 38 weeks, albumin below 3.0 g/dL, isoimmune hemolytic disease or G6PD deficiency, sepsis, or clinical instability in the prior 24 hours. When any of these are present, treatment is started at a lower TSB.
Follow-up timing now flows from a risk-based approach: the gap between the infant's current TSB and the phototherapy threshold determines how soon a repeat measurement or visit is needed. A baby discharged with a value close to the threshold needs to be seen sooner, sometimes within a day. A baby with a wide margin can be seen later. Translate that gap into a concrete plan before discharge, confirm the family has an appointment, and document the date, the rationale, and that the parents understood it. A specific return appointment, not a vague "follow up with your pediatrician," is the safety net that prevents readmission for severe jaundice.
Patient and family teaching
Teaching is where nurses move the needle most. Keep it concrete and tied to action.
- What jaundice is and how it looks. Explain that bilirubin builds up as the baby's liver matures, and that yellowing typically starts in the face and moves down to the chest, belly, arms, and legs as levels rise. Tell families to check in natural or white light and to look at the whites of the eyes. Caution parents of darker-skinned infants that skin color is harder to read, which is exactly why the blood or skin measurement matters.
- Feeding. Adequate intake helps clear bilirubin. For breastfeeding families, the AAP supports nursing at least 8 to 12 times a day in the early days, and connecting promptly with lactation support if latch, output, or weight is a concern. Frame good feeding as both nutrition and jaundice prevention.
- When to call. Give clear return precautions: deepening yellow color, yellowing spreading down to the abdomen or legs, a baby who is hard to wake, feeding poorly, very fussy, arching, or making fewer wet and dirty diapers. These are the signs that prompt a call or a visit, not a wait-and-see.
- Phototherapy. Reassure families that most jaundice needs no treatment, and that when it does, phototherapy uses special lights to lower the level. Explain whether it will happen in the hospital or at home and what monitoring to expect.
Documentation and workflow
Close the loop the way an audit would want to see it: the predischarge TSB or TcB value with the hour of life, the curve or calculator result, the neurotoxicity risk factors present or absent, the discharge plan with a specific follow-up date, and confirmation that teaching was given and understood. Use your facility's bilirubin nomogram tool exactly as built, and escalate per policy rather than adjusting thresholds on your own. The 2022 update gives nurses a clearer, more individualized framework. Your role is to feed it accurate numbers, act on the result, and send families home knowing what to watch and when to return.